Literature DB >> 34009433

Preoperative lymphocyte/C-reactive protein ratio and its correlation with CD8+ tumor-infiltrating lymphocytes as a predictor of prognosis after resection of intrahepatic cholangiocarcinoma.

Katsuki Miyazaki1, Yuji Morine1, Satoru Imura1, Tetsuya Ikemoto1, Yu Saito1, Shinichiro Yamada1, Kazunori Tokuda1, Shohei Okikawa1, Shoko Yamashita1,2, Takeshi Oya3, Koichi Tsuneyama2, Mitsuo Shimada4.   

Abstract

PURPOSE: To clarify whether the preoperative lymphocyte/C-reactive protein (CRP) ratio (LCR) is a prognostic factor for patients with intrahepatic cholangiocarcinoma (IHCC), and investigate its mechanism via tumor-infiltrating lymphocytes.
METHODS: The subjects of this retrospective study were 42 patients who had undergone hepatectomy for IHCC. We divided the patients into low LCR and high LCR groups (cutoff value: 8780) and analyzed their overall survival (OS) and disease-free survival (DFS) with respect to LCR and other clinicopathological factors. We also investigated the levels of stromal tumor-infiltrating lymphocytes (TILs) and CD8+ TILs in surgical specimens, and the relationship between LCR and TILs.
RESULTS: A low LCR was identified in 21 patients and was significantly correlated with older age, a high CRP-albumin ratio, and advanced disease stage, and was a prognostic factor for OS and DFS. Multivariate analysis revealed that a low LCR was an independent prognostic factor for worse OS (HR 10.40, P = 0.0077). Although the LCR and levels of stromal TILs were not significantly related, LCR and levels of CD8+ TILs were significantly related (P = 0.0297).
CONCLUSION: The preoperative LCR may predict the postsurgical prognosis of patients with IHCC and reflect the CD8+ TILs.
© 2021. Springer Nature Singapore Pte Ltd.

Entities:  

Keywords:  CD8+ tumor-infiltrating lymphocytes; Intrahepatic cholangiocarcinoma; Lymphocyte/C-reactive protein ratio; Stromal tumor-infiltrating lymphocytes

Mesh:

Substances:

Year:  2021        PMID: 34009433     DOI: 10.1007/s00595-021-02295-5

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  11 in total

Review 1.  The concept of the gene: short history and present status.

Authors:  P Portin
Journal:  Q Rev Biol       Date:  1993-06       Impact factor: 4.875

2.  C-reactive protein promotes bone destruction in human myeloma through the CD32-p38 MAPK-Twist axis.

Authors:  Jing Yang; Zhiqiang Liu; Huan Liu; Jin He; Jianling Yang; Pei Lin; Qiang Wang; Juan Du; Wencai Ma; Zheng Yin; Eric Davis; Robert Z Orlowski; Jian Hou; Qing Yi
Journal:  Sci Signal       Date:  2017-12-12       Impact factor: 8.192

3.  Preoperative prognostic nutritional index predicts survival of patients with intrahepatic cholangiocarcinoma after curative resection.

Authors:  Özgür Akgül; Fabio Bagante; Griffin Olsen; Jordan M Cloyd; Matthew Weiss; Katiuscha Merath; Sorin Alexandrescu; Hugo P Marques; Luca Aldrighetti; Shishir K Maithel; Carlo Pulitano; Todd W Bauer; Feng Shen; George A Poultsides; Olivier Soubrane; Guillaume Martel; B Groot Koerkamp; Alfredo Guglielmi; Endo Itaru; Timothy M Pawlik
Journal:  J Surg Oncol       Date:  2018-08-06       Impact factor: 3.454

4.  Clinical Discrimination of Chronic Pouchitis After Ileal Pouch-Anal Anastomosis in Patients with Ulcerative Colitis.

Authors:  Yoshiki Okita; Masaki Ohi; Takahito Kitajima; Tadanobu Shimura; Akira Yamamoto; Hiroyuki Fujikawa; Yoshinaga Okugawa; Kohei Matsushita; Yuhki Koike; Mikihiro Inoue; Keiichi Uchida; Yuji Toiyama
Journal:  J Gastrointest Surg       Date:  2020-11-02       Impact factor: 3.452

5.  Knockdown of nucleophosmin 1 suppresses proliferation of triple-negative breast cancer cells through activating CDH1/Skp2/p27kip1 pathway.

Authors:  Yingsheng Xiao; Jianling Zhu; Chunyan Peng; Weiquan Liang; Haoyu Lin
Journal:  Cancer Manag Res       Date:  2018-12-21       Impact factor: 3.989

6.  Prognostic value of inflammation-based indexes for intrahepatic cholangiocarcinoma following curative resection.

Authors:  Yunhua Wu; Fenggang Ren; Yichao Chai; Zhao Xue; Cong Shen; Xufeng Zhang; Yi Lv; Liangshuo Hu
Journal:  Oncol Lett       Date:  2018-10-24       Impact factor: 2.967

7.  Clinical characteristics and management of 1572 patients with pyogenic liver abscess: A 12-year retrospective study.

Authors:  Dalong Yin; Changyong Ji; Shugeng Zhang; Jiabei Wang; Zhaoyang Lu; Xuan Song; Hongchi Jiang; Wan Yee Lau; Lianxin Liu
Journal:  Liver Int       Date:  2020-12-28       Impact factor: 5.828

8.  C reactive protein impairs adaptive immunity in immune cells of patients with melanoma.

Authors:  Tatsuya Yoshida; Junya Ichikawa; Iulia Giuroiu; Andressa S Laino; Yuhan Hao; Michelle Krogsgaard; Melinda Vassallo; David M Woods; F Stephen Hodi; Jeffrey Weber
Journal:  J Immunother Cancer       Date:  2020-04       Impact factor: 13.751

9.  Phase Ib study of anti-CSF-1R antibody emactuzumab in combination with CD40 agonist selicrelumab in advanced solid tumor patients.

Authors:  Jean-Pascal Machiels; Carlos Gomez-Roca; Jean-Marie Michot; Dmitriy Zamarin; Tara Mitchell; Gaetan Catala; Lauriane Eberst; Wolfgang Jacob; Anna-Maria Jegg; Michael A Cannarile; Carl Watson; Galina Babitzki; Konstanty Korski; Irina Klaman; Priscila Teixeira; Sabine Hoves; Carola Ries; Georgina Meneses-Lorente; Francesca Michielin; Randolph Christen; Dominik Rüttinger; Martin Weisser; Jean-Pierre Delord; Philippe Cassier
Journal:  J Immunother Cancer       Date:  2020-10       Impact factor: 13.751

10.  Personalized Therapy of Chronic Hepatitis C and B Dually Infected Patients With Pegylated Interferon Plus Ribavirin: A Randomized Study.

Authors:  Ming-Lun Yeh; Ming-Yen Hsieh; Ching-I Huang; Chung-Feng Huang; Meng-Hsuan Hsieh; Po-Cheng Liang; Yi-Hung Lin; Nai-Jen Hou; Zu-Yau Lin; Shinn-Cherng Chen; Jee-Fu Huang; Chia-Yen Dai; Wan-Long Chuang; Ming-Lung Yu
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

View more
  3 in total

1.  Validation of the Japanese National Clinical Database Risk calculator for lung cancer surgery focused on postoperative morbidity.

Authors:  Yasuto Kondo; Yosuke Matsuura; Yohei Kawaguchi; Junji Ichinose; Masayuki Nakao; Sakae Okumura; Yukitoshi Satoh; Mingyon Mun
Journal:  Gen Thorac Cardiovasc Surg       Date:  2021-03-08

2.  C-reactive protein to lymphocyte count ratio is a promising novel marker in hepatitis C infection: the clear hep-c study.

Authors:  Muhammed Emin Demirkol; Gulali Aktas; Satilmiş Bilgin; Gizem Kahveci; Ozge Kurtkulagi; Burcin Meryem Atak; Tuba Taslamacioglu Duman
Journal:  Rev Assoc Med Bras (1992)       Date:  2022-06-24       Impact factor: 1.712

Review 3.  Tumor Microenvironment and its Implications for Antitumor Immunity in Cholangiocarcinoma: Future Perspectives for Novel Therapies.

Authors:  Hengsong Cao; Tian Huang; Mingrui Dai; Xiangyi Kong; Hanyuan Liu; Zhiying Zheng; Guoqiang Sun; Guangshun Sun; Dawei Rong; Zehua Jin; Weiwei Tang; Yongxiang Xia
Journal:  Int J Biol Sci       Date:  2022-08-21       Impact factor: 10.750

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.